Mahesh K B Parmar Selected Research

Prostate-Specific Antigen (Semenogelase)

5/2024	Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
5/2024	Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
1/2022	Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
10/2020	Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data.
3/2016	Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE Trial.
7/2015	Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer.
4/2014	Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial.
5/2012	Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial.
12/2011	Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mahesh K B Parmar Research Topics

Disease

47	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 09/2003
12	Neoplasms (Cancer) 02/2023 - 05/2003
11	Neoplasm Metastasis (Metastasis) 05/2024 - 09/2003
8	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 07/2003
4	Disease Progression 01/2022 - 06/2007
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 02/2010
4	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 05/2010
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 03/2015
3	Hypertension (High Blood Pressure) 01/2022 - 12/2011
3	COVID-19 01/2022 - 04/2021
3	Adenocarcinoma 01/2022 - 01/2016
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2020 - 05/2010
3	Colorectal Neoplasms (Colorectal Cancer) 10/2012 - 06/2008
2	Opiate Overdose 01/2017 - 02/2015
2	Urinary Bladder Neoplasms (Bladder Cancer) 06/2011 - 10/2009
1	Melanoma (Melanoma, Malignant) 01/2023
1	Kidney Neoplasms (Kidney Cancer) 01/2023
1	Sudden Death 01/2022
1	Septic Shock (Toxic Shock Syndrome) 01/2022
1	Carcinoma (Carcinomatosis) 01/2021
1	Urinary Incontinence 10/2020
1	Urethral Stricture 10/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2017
1	Nasopharyngeal Carcinoma 01/2017
1	Multiple Endocrine Neoplasia Type 2a (MEN 2) 03/2016
1	Hypothyroidism 03/2016
1	Neutropenia 03/2016
1	Sarcoidosis (Schaumann Disease) 08/2015
1	Fistula 08/2015
1	Heart Failure 08/2015
1	Respiratory Insufficiency (Respiratory Failure) 10/2013
1	Testicular Neoplasms (Testicular Cancer) 04/2012
1	Body Weight (Weight, Body) 12/2011
1	Pathologic Complete Response 10/2010

Drug/Important Bio-Agent (IBA)

24	Hormones (Hormone)IBA 02/2023 - 09/2003
20	AndrogensIBA 05/2024 - 06/2007
9	Prostate-Specific Antigen (Semenogelase)IBA 05/2024 - 12/2011
9	abirateroneIBA 02/2023 - 11/2014
8	Docetaxel (Taxotere)FDA Link 01/2023 - 02/2009
8	Abiraterone AcetateIBA 01/2023 - 01/2017
6	Prednisolone (Predate)FDA LinkGeneric 01/2023 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2008
4	Diphosphonates (Bisphosphonates)IBA 02/2016 - 09/2003
3	enzalutamideIBA 01/2023 - 11/2014
3	Monoclonal AntibodiesIBA 01/2022 - 10/2012
3	Carboplatin (JM8)FDA LinkGeneric 01/2019 - 12/2011
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 12/2011
3	Bevacizumab (Avastin)FDA Link 01/2019 - 12/2011
3	Celecoxib (Celebrex)FDA Link 05/2017 - 02/2009
3	Zoledronic Acid (Zometa)FDA Link 05/2017 - 02/2009
3	Clodronic Acid (Clodronate)IBA 09/2009 - 09/2003
2	antiarrhythmic peptide (AAP)IBA 10/2022 - 01/2022
2	Prednisone (Sone)FDA LinkGeneric 10/2022 - 01/2022
2	bamlanivimabIBA 01/2022 - 11/2021
2	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 12/2020
2	remdesivirIBA 01/2022 - 11/2021
2	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 06/2008
2	Naloxone (Narcan)FDA LinkGeneric 01/2017 - 02/2015
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2017 - 01/2016
2	PlatinumIBA 03/2016 - 10/2010
2	Cisplatin (Platino)FDA LinkGeneric 06/2011 - 05/2008
2	Vinblastine (Vinblastine Sulfate)FDA Link 06/2011 - 05/2008
2	Fluorouracil (Carac)FDA LinkGeneric 02/2010 - 06/2008
1	InterferonsIBA 02/2023
1	Androgen Receptors (Androgen Receptor)IBA 02/2023
1	pembrolizumabIBA 01/2023
1	Acetates (Acetic Acid Esters)FDA Link 01/2022
1	Alanine (L-Alanine)FDA Link 01/2022
1	AntigensIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 04/2021
1	VaccinesIBA 04/2021
1	ParaffinIBA 11/2020
1	Formaldehyde (Formol)FDA Link 11/2020
1	Dihydrotachysterol (AT 10)IBA 10/2020
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2017
1	cediranib (AZD2171)IBA 03/2016
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 03/2016
1	Testosterone (Sustanon)FDA Link 01/2016
1	Tyrosine Kinase InhibitorsIBA 05/2015
1	ErbB Receptors (EGF Receptor)IBA 05/2015
1	Opiate AlkaloidsIBA 10/2013
1	Heroin (Diamorphine)IBA 10/2013
1	Methotrexate (Mexate)FDA LinkGeneric 06/2011
1	Interferon alpha-2 (Roferon-A)FDA Link 02/2010

Therapy/Procedure

40	Therapeutics 05/2024 - 09/2003
28	Radiotherapy 05/2024 - 05/2003
16	Drug Therapy (Chemotherapy) 01/2021 - 07/2003
4	Prostatectomy (Retropubic Prostatectomy) 05/2024 - 10/2020
2	Nephrectomy 01/2022 - 01/2021
2	Chemoradiotherapy 01/2021 - 01/2017
2	Adjuvant Radiotherapy 10/2020 - 10/2020
2	Neoadjuvant Therapy 12/2018 - 06/2011
2	Conformal Radiotherapy 04/2014 - 06/2007
2	Cystectomy 06/2011 - 05/2003
1	Immunotherapy 01/2023
1	Resuscitation 01/2017
1	Adjuvant Chemotherapy 03/2015
1	Orchiectomy (Orchidectomy) 04/2012
1	Treatment Delay 10/2010